The Use of ACE inhibitors and Angiotensin Receptor Blockers in Patients with COVID-19
Listen to CMHC's Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEis and ARBs should be withdrawn in patients with COVID-19.
Information
- Show
- PublishedApril 20, 2020 at 4:08 PM UTC
- Length10 min
- RatingClean